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Aims: Diabetes mellitus is a metabolic disorder characterised by inadequate pancreatic insulin secretion or the insulin present 
being unable to perform its function properly. Consistent with the beneficial effects of probiotics and their ability to lower 
glucose levels, an impact on diabetes treatment is also expected. The aim of this study was to evaluate the effect of Lactobacillus 
casei on various either biochemical parameters in a diabetic mice model.
Methods: In the present study, 24 mice were divided into diabetic and control groups. Further, each group was categorised 
into two subgroups. The diabetic and control subgroups were fed carrot juice or Lactobacillus casei in carrot juice. Diabetes was 
induced by streptozotocin (STZ). For 30 days, the mice were fed 2 ml carrot juice, and Lactobacillus casei in carrot juice (with 
lactobacillus 109 cfu/ml) by gavage. Then, blood samples were collected to assay biochemical parameters.
Results: The results of this study showed that Lactobacillus casei (ATCC39392) significantly reduced blood glucose (BG) levels in 
diabetic mice receiving the probiotic, but did not cause a significant change in BG levels in control mice receiving the probiotic. 
When comparing insulin, insulin-like growth factor I (IGF-I) and C-peptide in the four groups, it was found that insulin and 
C-peptide were significantly different in all groups except for the control group treated with a mixture of probiotic Lactobacillus 
casei and carrot juice.
Conclusion: Our results showed that probiotic Lactobacillus casei effectively reduces BG levels in diabetic mice treated with this 
bacterium.
Keywords: diabetes, Lactobacillus casei, probiotic
Introduction
Diabetes mellitus (DM) is one of the most common metabolic 
diseases in the world.1,2 According to a WHO report, nearly 171 
million people are afflicted with this disease. It is predicted that 
by 2030 the figure will hit 366 million. Any disorder in the 
function of pancreatic β-cells will lead to hyperglycaemia 
whereby if the immune system interferes in the appearance of 
such disorders it is called diabetes type 1 and if receptive cells 
resist against insulin it is called diabetes type 2.4,5 This disease 
may lead to long-term complications like nephropathy, 
neuropathy, retinopathy, brain stroke and heart attack and even 
malformation.6–9 Nowadays, different approaches are employed 
to treat this disease.10 Discovering new methods to prevent and 
treat DM has been highly prioritised. Meanwhile, probiotics that 
contain live microorganisms can have healing effects provided 
that the host uses a sufficient dose.11 Bacteria producing lactic 
acid, especially lactobacillus, are commonly considered to be 
part of the digestive system ecosystem. Proven potential effects 
of probiotic microorganisms include aiding digestion of lactose 
in the intestine, alleviating diarrhoea and constipation, 
decreasing cholesterol level, controlling colon cancer, reinforcing 
of the immune system, stimulating intestinal microflora growth, 
preventing increases in allergic reactions, and restraining 
pathogen growth in the intestine.3,12 Hence, in line with the 
positive effects of probiotics and increasing spread of DM and 
scarcity of studies concerning this issue, the present study 
probes the effects of Lactobacillus casei on biochemistry factors 
in diabetic Syrian mice so as to determine the effects of using 
probiotics to help treat DM.
Materials and methods
In this study, 24 female mice whose weight ranged from 28 to 32 
grams were obtained from the research centre of Tabriz University of 
Medical Sciences. Prior to the experiment, in order to make the mice 
under study compatible, they were kept at 25  ±  2°C under equal 
conditions of light and dark in special cages where they had access 
to sufficient water and typical food. The mice were then categorised 
into two groups and a further two subgroups. The diabetic and 
control subgroups received carrot juice and Lactobacillus casei in 
carrot juice (Figure 1). The animal care methods and experimental 
procedures employed were approved by the Animal Ethics 
Committee of the Tabriz University of Medical Sciences.
In order to induce DM in the mice, streptozotocin (STZ) with the 
trade name Zanosar®, purchased from Sigma Aldrich (St Louis, 
MO, USA) and dissolved in a citrate buffer, was injected 
intraperitoneally at a dose of 60 mg/kg of body weight. Ten days 
after injection, some signs like overeating, over-drinking and 
frequent urination were observed. To ensure that the mice were 
diabetic, blood glocuse (BG) levels were measured with a 
glucometer and mice with a blood glucose level exceeding 
200 mg/dl were considered diabetic.
Lactobacillus casei (ATCC39392) was obtained from collection 
and industrial bacteria of Iran regional centre as lyophilised 
ampoules. With a sterile Pasteur pipette, 0.3–0.4  ml sterile 
solution (growth medium for liquid or normal saline) was added 
to the dried material in the ampoule and was mixed to ultimately 
a uniform suspension. Then, the bacterium was cultivated in MRS 
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cultivation broth. Finally, through gram staining and catalase 
and oxidase tests, it was ascertained that the mentioned 
bacterium was a gram-positive bacillus of lactobacillus. In order 
to gavage-feed the mice, 5 ml bacterium was cultivated in MRS 
cultivation broth. After 48 hours’ incubation in an incubator 
containing 10% carbon dioxide, the bacteria were separated in a 
centrifuge at a speed of 6000 rpm for 15 minutes. After washing 
with normal saline and centrifuging again, the pipes containing 
sterile distilled water were filled with bacteria until an opacity 
equalling 0.5 using McFarland’s standard was reached. 
Meanwhile, light absorption of the microbial suspension at a 
wavelength of 600 nanometres was determined and recorded. 
The pour plate method was used to determine the number of 
bacteria in microbial suspension and in fact to attain colony 
forming units/ml (CFU/ml). Ultimately, a bacterial suspension of 
109  cfu/ml density was attained. Then, 1  ml of bacterial 
suspension was blended with 4 ml carrot juice (Daucus carota). 
Thereafter, 2  ml of this mixture was fed to the second healthy 
group and the fourth diabetic group in the form of gavage every 
day for 30 days. The healthy and the diabetic groups were fed 
carrot juice only for 30 days.13
At the end of the treatment period, after 12 hours’ fasting, mice 
were anaesthetised and a blood specimen collected (the mice 
were weighed before and after treatment).
The collected blood was centrifuged at 3000  rpm to separate 
blood serum. Measurement of blood glucose level was carried 
out by the Enzymatic-Colorimetric GOD-PAP method. Insulin, 
insulin-like growth factor I (IGF-I) and C-peptide were measured 
using the ELISA technique (kit from Monobind Inc, Lake Forest, 
CA, USA).
All of the statistical methods were done using SPSS16® software 
(SPSS Inc, Chicago, IL, USA). The graphs were drawn using 
GraphPad Prism® (version 6) software (San Diego, CA, USA); 
variables were expressed as mean ± SD.
Results
To compare data in various groups the one-way ANOVA test was 
used. The distribution of all data in this study was normal. In 
order to find out the various group changes, a Tukey post hoc 
test was performed to make a pairwise comparison. Results 
showed that all the groups had significant differences in 
comparison one another (p-value  =  0.001), except that the 
healthy control group receiving carrot juice and the healthy 
control group receiving probiotic Lactobacillus casei were not 
significantly different (p-value = 0.99) (Figure 2).
All the data from insulin, IGF-1 and C-peptide in serum were 
statistically analysed and these variables had a normal 
distribution. The results of the ANOVA test on insulin showed a 
significant discrepancy between the diabetic group who 
received carrot juice and the diabetic group treated with a 
mixture of probiotic Lactobacillus casei (p-value = 0.03), and the 
control group treated with a mixture of probiotic Lactobacillus 
casei and carrot juice too (p-value = 0.01); in the other groups no 
significant differences were seen (Figure 3).
The ANOVA test was used to consider the discrepancy among 
IGF-1 values in the four groups and the results showed that IGF-1 
value in all four groups showed no significant difference. Thus 
among all groups IGF-1 is not changed (Figure 4), which means 
that carrot juice and probiotic Lactobacillus casei have no effect 
on diabetic and control groups.
When considering the different values of C-peptide, the ANOVA 
test showed significant results in three groups (p-value  =  0.02 
and 0.03). The results showed that except for the control group 
treated with a mixture of probiotic Lactobacillus casei and carrot 
juice, pairwise consideration and comparisons of the other 
groups showed a significant discrepancy (Figure 5). The 
mean ± SD of glucose, insulin, IGF-1 and C-peptide of four groups 
is given in Table 1.
Discussion
In 2007, Yadav et al. studied the effects of an anti-diabetes-
containing lactobacillus Dahi produced by probiotic casei and 
acidophilus on rats induced with diabetes by fructose and 
showed that the probiotic caused a decrease in blood sugar level 
and glucose intolerance.14 Further, in another study on rats with 
STZ-induced diabetes they showed that the blood sugar level 
drops significantly as a result of this probiotic. They attributed it 
to reinforcement of the antioxidant system with probiotics and a 
decrease in the destruction of beta-cells of the islets of 
Figure 1: Categorisation of mice into two groups and two subgroups in 
this study.
Figure 2: Changes in serum levels of glucose.
*Significance of data comparing diabetic group treated with carrot juice vs. the 
other groups (p = 0.001). **Significance of data comparing diabetic group treated 
with mixture of Lactobacillus casei and carrot juice vs. the other groups (p = 0.001). 
†Significances of data comparing control group treated with carrot juice with 
diabetic groups (p = 0.001). ‡Significance of data comparing control group treated 
with mixture of Lactobacillus casei and carrot juice with diabetic groups  
(p = 0.001). CJ = carrot juice and CB = casei bacterium.
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Langerhans.15 In 2007, Lali et al. proved that a Nano product 
containing lactobacillus causes a decrease in blood sugar of mice 
with diabetes through aloxone.11 In 2009, Harissa et al. showed 
that Lactobacillus acidophilus causes a decrease in free radicals 
and reactive oxygen species (ROS). These reactive compounds 
cause a disorder in the nitric oxide strain of diabetic rats. Nitric 
oxide is an important medium in the secretion of hormones and 
stimulation of the immune system. In other words, Lactobacillus 
acidophilus leads to a decrease in blood sugar and adjustment of 
nitric oxide in rats with aloxone-induced diabetes.16
In 1997, Matzvky et al. demonstrated that Lactobacillus casei in KK-
AY mice with genetically induced diabetes type 2 caused a 
decrease in blood sugar.17 In this study the effect of probiotic 
Lactobacillus casei strain TD2 on blood sugar was investigated. The 
results indicated that the blood sugar in diabetic rats showed a 
significant decrease in comparison with a diabetic control group 
after consuming the probiotic for 21 days. It was also shown that 
the probiotic strain does not comprise a complete treatment of 
diabetes; however, it can be used as a controlling treatment.
Various mechanisms have been suggested for decreasing 
cholesterol by means of probiotics. It is likely that when the 
amount of lactobacillus increases in the intestine, the demand 
for glucose goes up and as a result leads to a decrease in released 
glucose in serum.11,14 Further, because probiotics have an 
antioxidant trait, they prevent destruction of β-Langerhans cells 
Figure 4: Changes in serum levels of IGF-1. CJ = carrot juice and CB = 
casei bacterium.
Table 1: Concentration (mean ± SD) of glucose, insulin, IGF-I and 































128±11.7 4.66±0.9 0.95±0.03 0.17±0.01
Figure 3: Changes in serum levels of insulin.
*Significance of data comparing diabetic group treated with carrot juice 
vs. diabetic group treated with mixture of Lactobacillus casei and carrot 
juice and control group treated with mixture of Lactobacillus casei and 
carrot juice (p = 0.03 and 0.01). **Significance of data comparing control 
group treated with mixture of Lactobacillus casei and carrot juice vs. 
diabetic group treated with carrot juice (p = 0.01). CJ = carrot juice and 
CB = casei bacterium.
Figure 5: Changes in serum levels of C-peptide.
*Significance of data comparing diabetic group treated with carrot 
juice vs. diabetic group treated with mixture of Lactobacillus casei and 
carrot juice (p = 0.005). **Significance of data comparing diabetic group 
treated with mixture of Lactobacillus casei and carrot juice vs. diabetic 
group treated with carrot juice and control group treated with carrot 
juice (p = 0.005 and 0.01). †Significance of data comparing control 
group treated with carrot juice vs. diabetic group treated with mixture 
of Lactobacillus casei and carrot juice (p = 0.01). CJ = carrot juice and  
CB = casei bacterium.
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and as a result cause serum glucose to decrease.16 The structure 
of intestinal microflora is effective in determining inflammation, 
which plays a role in diabetes. This is done when the equilibrium 
in the intestinal microflora is violated and gram-positive bacteria 
in the intestine decrease compared to gram-negative bacteria. 
As a result, the absorption of lipopolysaccharide and other pre-
inflammation molecules and the rate of their transition to blood 
circulation increase. Hence, this leads to an increase in cytokine 
secretion, activity of macrophages, and outbreaks of 
inflammation. Inflammatory cytokines cause a disorder in the 
function of insulin receptors and as a result a resistance to insulin. 
Moreover, through induction of apoptosis, β-pancreases cells 
cause the secretion of insulin by these cells to decrease.18–20
In general, probiotics have been the centre of attention because 
of their bold effects on treating acute gastrointestinal 
inflammation, diarrhoea, constipation, irritable bowel syndrome, 
colorectal cancer, etc. Probiotics are used as food supplements 
but in the medical industry they can be used as auxiliary medicine 
with few side effects to decrease blood sugar. Researchers 
attribute the decrease in blood sugar to an increase in the 
number of lactobacilli in the intestine which consume glucose 
and thereby limit glucose absorption and distribution to other 
organs in the host.11,14,21
Nevertheless, more studies are required to define the exact 
mechanism of this process and it is likely that other lactobacilli 
possess this characteristic. Through more research, it may be 
possible to discover a simpler way to prevent and treat diabetes. 
The results of this study also show the efficacy of Lactobacillus 
casei in controlling blood sugar in diabetic mice. Further, the 
results show that probiotics in healthy mice do not cause blood 
sugar to decrease, which is of great importance. Therefore, it 
seems that the products of this probiotic can be considered an 
appropriate supplementary medicine for controlling blood 
sugar. However, it should be mentioned that various clinical 
studies are required to determine the accurate mechanism of 
this probiotic and its daily consumption.
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